Evidence map›Paper›PMID 37398114›Full record

ArticlebioRxiv : the preprint server for biology2023

Yang Yu, Wen-Ming Cao, Feng Cheng, Zhongcheng Shi, Lili Han, Jin-Ling Yi, Edaise M da Silva, Higinio Dopeso, Hui Chen, Jianhua Yang and 3 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Yang YuCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Wen-Ming CaoDepartment of Pathology & Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Feng ChengCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Zhongcheng ShiAdvanced Technology Cores, Baylor College of Medicine, Houston, USA.
Lili HanDepartment of Pathology & Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jin-Ling YiTexas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Edaise M da SilvaDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Higinio DopesoDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hui ChenDepartment of Pathology & Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jianhua YangCenter for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Xiaosong WangDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
Chunchao ZhangTexas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Hong ZhangDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Baylor College of Medicine · USChildren's National · USMemorial Sloan Kettering Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Pittsburgh · US

Funding

CAMKV Kinase Signaling in NeuroblastomaR01NS118008 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI YANG, JIANHUA · 2020 to 2024
$2.2M
NINDS NIH HHS R01 NS118008
6 · The paper itself

Abstract

Activation of oncogenes through DNA amplification/overexpression plays an important role in cancer initiation and progression. Chromosome 17 has many cancer-associated genetic anomalies. This cytogenetic anomaly is strongly associated with poor prognosis of breast cancer.

Indexed as

Breast cancerCCNE2cell proliferationESR1FOXK2PDK1

Identifiers

PMID37398114
PMCPMC10312425
OpenAlexW4379106463

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.